Existing antimicrobial agents face diminishing efficacy due to evolving pathogen resistance. Identifying novel peptide sequences from extreme environments provides new mechanisms to overcome current treatment failures.

Enzymatic processes suffer from rapid denaturation and loss of activity under industrial thermal conditions. Enhancing structural robustness prevents premature catalyst degradation and maintains reaction throughput.

Inefficient conversion rates and low product concentrations in aqueous enzymatic systems limit industrial viability. Overcoming these bottlenecks increases volumetric productivity for high-value sweeteners and rare sugars.